75A50124F61001↗
Advanced Technology International received this contract from Barda - Aspr / Daappo / Barda Dcma, Office of Assistant Secretary for Preparedness and Response: $32.00M obligated so far for health r&d services; health care - other; applied research. It runs to 2027-12-31.
Key facts · data as of Oct 25, 2026
- Recipient
- Advanced Technology International
- Awarding agency
- Office of Assistant Secretary for Preparedness and Response (Department of Health and Human Services)
- Contracting office
- Barda - Aspr / Daappo / Barda Dcma (75A501)
- Obligated to date
- $32.00M
- Potential value
- $32.00M
- Ends
- 2027-12-31
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 75A50124F61001, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75A50124F61001_7505_75A50123D00003_7505
Advanced Technology International: all federal awards · Department of Health and Human Services: spending · Barda - Aspr / Daappo / Barda Dcma: what it buys · The follow-on: recompete brief
OTHER TRANSACTION: PRODUCTION OF THREE (3) BIOLOGICALLY DERIVED SMALL MOLECULE REGULATORY STARTING MATERIALS AND/OR ACTIVE PHARMACEUTICAL INGREDIENTS AT COMMERCIAL SCALE UNDER THE BIOMAP-CONSORTIUM
Up for re-bid: ends 2027-12-31. Recompete brief →
What it is
- Product or service
- Health R&D Services; Health Care - Other; Applied Research (PSC AN42)
- Industry
- Biological Product (Except Diagnostic) Manufacturing (NAICS 325414)
- Contracting office
- Barda - Aspr / Daappo / Barda Dcma (75A501)
- Competition
- Full and open competition
- Pricing
- Cost plus fixed fee
- How it was bought
- Single-award IDIQ · under 75A50123D00003
- Where the work is
- Berkeley, SC · district SC-01
- Funding law
- COVID-19 laws
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
7 actions since 2023-12-12. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-02-23 | P00006 | Supplemental agreement (work within scope) | $0 | OT: THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE. |
| 2025-10-29 | P00005 | Administrative change | $0 | OT: THE PURPOSE OF THIS MODIFICATION IS TO UPDATE ATTACHMENT 1, SECTION 7: TASK ORDER POINTS OF CONTACT. |
| 2025-04-23 | P00004 | Supplemental agreement (work within scope) | $0 | OT: THE PURPOSE OF THIS MODIFICATION IS TO DELETE THE STATEMENT OF OBJECTIVES (SOO) DATED 12/11/2023 IN ITS ENTIRETY AND REPLACE IT WITH THE REVISED SOO DATED 04/23/2025. |
| 2025-01-08 | P00003 | Administrative change | $0 | OT: THE PURPOSE OF THIS MODIFICATION IS TO UPDATE SECTION 7: TASK ORDER POINTS OF CONTACT BY CHANGING THE HHS/ASPR OTHER TRANSACTION AUTHORITY OFFICER (OTAO) FROM CHRISTOPHER WEAVER TO LORI FISCHER. |
| 2024-11-15 | P00002 | Administrative change | $0 | OT: THE PURPOSE OF THIS MODIFICATION IS TO TRANSFER TASK ORDER 75A50124F61001 FROM ASPR/BARDA/PCI TO ASPR INDUSTRIAL BASE MANAGEMENT AND SUPPLY CHAIN (IBMSC) |
| 2024-09-20 | P00001 | Administrative change | $0 | OTHER TRANSACTION: TO (1) INCORPORATE REVISED OT BASE AGREEMENT 75A50123D00003, DATED AUGUST 29, 2024, BY REFERENCE; AND (2) REVISE THE COMPLETION DATE ON THE ORDER, INCLUDING LINES 1 AND 2, TO 09/30/2026. |
| 2023-12-12 | 0 | $32.00M | OTHER TRANSACTION: PRODUCTION OF THREE (3) BIOLOGICALLY DERIVED SMALL MOLECULE REGULATORY STARTING MATERIALS AND/OR ACTIVE PHARMACEUTICAL INGREDIENTS AT COMMERCIAL SCALE UNDER THE BIOMAP-CONSORTIUM |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗